Eyad Almasri, MD
Professor
Pulmonology - Fresno
School of Medicine

Clinical Professor, UCSF

Eyad Almasri, M.D., specializes in pulmonary disease. He is board certified in Internal Medicine, Pulmonary, Critical Care and Sleep Medicine.

Dr. Almasri completed a fellowship in critical care medicine at the University of Pittsburgh and an additional fellowship in pulmonary medicine at Western Pennsylvania Hospital.

Dr. Almasri is a member of the American College of Chest Physicians (ACCP), the Society of Critical Care Medicine, and the American Medical Association.

He enjoys camping, swimming and traveling with his family.

• Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray.
  Molecular cytogenetics 2023 Soster E, Tynan J, Gibbons C, Meschino W, Wardrop J, Almasri E, Schwartz S, McLennan G
• Positive cfDNA screening results for 22q11.2 deletion syndrome-Clinical and laboratory considerations.
  Frontiers in genetics 2023 Soster E, Dyr B, Rafalko J, Almasri E, Cacheris P
• Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
  Annals of internal medicine 2022 ACTIV-3/TICO Study Group, Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM, Rogers R, Shehadeh F, Kaczynski M, Mylona EK, Syrigos KN, …
• Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
  The Lancet. Respiratory medicine 2022 Wolfe CR, Tomashek KM, Patterson TF, Gomez CA, Marconi VC, Jain MK, Yang OO, Paules CI, Palacios GMR, Grossberg R, Harkins MS, Mularski RA, Erdmann N, Sandkovsky U, Almasri E, Pineda JR, Dretler AW, …
• Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas.
  Transplantation and cellular therapy 2021 Goodman AM, Holden KA, Jeong AR, Kim L, Fitzgerald KD, Almasri E, McLennan G, Eisenberg M, Jahromi AH, Hoh C, Hurley M, Mulroney C, Tzachanis D, Ball ED, Jensen TJ, Kurzrock R
• Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible.
  Molecular cancer therapeutics 2021 Jensen TJ, Goodman AM, Ellison CK, Holden KA, Kato S, Kim L, Daniels GA, Fitzgerald K, McCarthy E, Nakashe P, Mazloom AR, Almasri E, McLennan G, Grosu DS, Eisenberg M, Kurzrock R
• Correction to: Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy number variants.
  Genetics in medicine : official journal of the American College of Medical Genetics 2021 Soster E, Boomer T, Hicks S, Caldwell S, Dyr B, Chibuk J, Almasri E
• Genome-wide cell-free DNA screening: a focus on copy-number variants.
  Genetics in medicine : official journal of the American College of Medical Genetics 2021 Rafalko J, Soster E, Caldwell S, Almasri E, Westover T, Weinblatt V, Cacheris P
• Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants.
  Genetics in medicine : official journal of the American College of Medical Genetics 2021 Soster E, Boomer T, Hicks S, Caldwell S, Dyr B, Chibuk J, Almasri E
• Application of mosaicism ratio to multifetal gestations.
  PloS one 2021 Rafalko J, Caldwell S, Soster E, Almasri E, McLennan G, Liu T, Weinblatt V, Cacheris P, McCullough R
• Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.
  Prenatal diagnosis 2021 Caldwell S, Almasri E, Schmidt L, Xu C, Dyr B, Wardrop J, Cacheris P
• Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
  JAMA 2020 Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR, Files DC, Gibbs KW, Ginde AA, Gong MN, Harrell FE, Hayden DL, Hough CL, Johnson NJ, …
• Impact of mosaicism ratio on positive predictive value of cfDNA screening.
  Prenatal diagnosis 2020 Rafalko JM, Caldwell S, Tynan J, Almasri E, Weinblatt V, McCullough R
• Cell-free DNA screening in twin pregnancies: A more accurate and reliable screening tool.
  Prenatal diagnosis 2020 Chibuk J, Rafalko J, Boomer T, McCullough R, McLennan G, Wyatt P, Almasri E
• A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory.
  PloS one 2019 Dyr B, Boomer T, Almasri EA, Wardrop JL, Rafalko J, Chibuk J, McCullough RM
• Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
  Clinical chemistry 2017 Dharajiya NG, Grosu DS, Farkas DH, McCullough RM, Almasri E, Sun Y, Kim SK, Jensen TJ, Saldivar JS, Topol EJ, van den Boom D, Ehrich M
• Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases.
  Genetics in medicine : official journal of the American College of Medical Genetics 2017 Ehrich M, Tynan J, Mazloom A, Almasri E, McCullough R, Boomer T, Grosu D, Chibuk J
• Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants.
  American journal of obstetrics and gynecology 2016 Lefkowitz RB, Tynan JA, Liu T, Wu Y, Mazloom AR, Almasri E, Hogg G, Angkachatchai V, Zhao C, Grosu DS, McLennan G, Ehrich M
• Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing.
  Prenatal diagnosis 2015 Helgeson J, Wardrop J, Boomer T, Almasri E, Paxton WB, Saldivar JS, Dharajiya N, Monroe TJ, Farkas DH, Grosu DS, McCullough RM
• Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing.
  Prenatal diagnosis 2015 Kinnings SL, Geis JA, Almasri E, Wang H, Guan X, McCullough RM, Bombard AT, Saldivar JS, Oeth P, Deciu C
• Uterine leiomyoma confounding a noninvasive prenatal test result.
  Prenatal diagnosis 2015 Dharajiya NG, Namba A, Horiuchi I, Miyai S, Farkas DH, Almasri E, Saldivar JS, Takagi K, Kamei Y
• Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples.
  PloS one 2014 McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, Deciu C, Oeth P, Bombard AT, Paxton B, Dharajiya N, Saldivar JS
• Rank-based edge reconstruction for scale-free genetic regulatory networks.
  BMC bioinformatics 2008 Chen G, Larsen P, Almasri E, Dai Y
• A statistical method to incorporate biological knowledge for generating testable novel gene regulatory interactions from microarray experiments.
  BMC bioinformatics 2007 Larsen P, Almasri E, Chen G, Dai Y
• Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis.
  Chest 2006 Kellum JA, Song M, Almasri E
• Correlated Discretized Expression score: a method for identifying gene interaction networks from time course microarray expression data.
  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006 Larsen P, Almasri E, Chen G, Dai Y
• Sample scale-free gene regulatory network using gene ontology.
  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006 Chen G, Larsen P, Almasri E, Dai Y
• Water and solute permeability of rat lung caveolae: high permeabilities explained by acyl chain unsaturation.
  American journal of physiology. Cell physiology 2005 Hill WG, Almasri E, Ruiz WG, Apodaca G, Zeidel ML
• Sumatriptan-associated ischemic colitis.
  Digestive diseases and sciences 2002 Naik M, Potluri R, Almasri E, Arnold GL